Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy
about
Involvement of substance P and the NK-1 receptor in human pathology.2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.
P2860
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy
description
scientific article published on 30 December 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2012
@uk
name
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@en
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@nl
type
label
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@en
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@nl
prefLabel
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@en
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@nl
P2093
P2860
P50
P1476
Results of a 7-day aprepitant ...... d germ cell tumor chemotherapy
@en
P2093
A McDonald
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
C Underhill
M R Stockler
P Grimison
P2860
P2888
P304
P356
10.1007/S00520-012-1696-0
P577
2012-12-30T00:00:00Z